{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:51:32Z","timestamp":1784253092472,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Riset Muhammadiyah (RisetMu) Batch VI","award":["1687.032\/PP\/I.3\/D\/2022"],"award-info":[{"award-number":["1687.032\/PP\/I.3\/D\/2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetic foot ulcers (DFUs) are a common complication of diabetes and can lead to severe disability and even amputation. Despite advances in treatment, there is currently no cure for DFUs and available drugs for treatment are limited. This study aimed to identify new candidate drugs and repurpose existing drugs to treat DFUs based on transcriptomics analysis. A total of 31 differentially expressed genes (DEGs) were identified and used to prioritize the biological risk genes for DFUs. Further investigation using the database DGIdb revealed 12 druggable target genes among 50 biological DFU risk genes, corresponding to 31 drugs. Interestingly, we highlighted that two drugs (urokinase and lidocaine) are under clinical investigation for DFU and 29 drugs are potential candidates to be repurposed for DFU therapy. The top 5 potential biomarkers for DFU from our findings are <jats:italic>IL6ST, CXCL9, IL1R1, CXCR2,<\/jats:italic> and <jats:italic>IL10<\/jats:italic>. This study highlights <jats:italic>IL1R1<\/jats:italic> as a highly promising biomarker for DFU due to its high systemic score in functional annotations, that can be targeted with an existing drug, Anakinra. Our study proposed that the integration of transcriptomic and bioinformatic-based approaches has the potential to drive drug repurposing for DFUs. Further research will further examine the mechanisms by which targeting <jats:italic>IL1R1<\/jats:italic> can be used to treat DFU.<\/jats:p>","DOI":"10.1038\/s41598-023-37120-1","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T17:02:41Z","timestamp":1687280561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer"],"prefix":"10.1038","volume":"13","author":[{"given":"Wirawan","family":"Adikusuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainul Amiruddin","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalu Muhammad","family":"Irham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiq Leny","family":"Nopitasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pradiningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdayani","family":"Firdayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdi Wira","family":"Septama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rockie","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"37120_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho, N. H. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271\u2013281. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.023 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"37120_CR2","doi-asserted-by":"publisher","first-page":"1 e1","DOI":"10.1016\/j.jaad.2013.06.055","volume":"70","author":"A Alavi","year":"2014","unstructured":"Alavi, A. et al. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J. Am. Acad. Dermatol. 70, 1 e1-18. https:\/\/doi.org\/10.1016\/j.jaad.2013.06.055 (2014).","journal-title":"J. Am. Acad. Dermatol."},{"key":"37120_CR3","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong, D. G., Boulton, A. J. M. & Bus, S. A. Diabetic foot ulcers and their recurrence. N Engl. J. Med. 376, 2367\u20132375. https:\/\/doi.org\/10.1056\/NEJMra1615439 (2017).","journal-title":"N Engl. J. Med."},{"key":"37120_CR4","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1007\/s00125-008-1089-6","volume":"51","author":"L Prompers","year":"2008","unstructured":"Prompers, L. et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia 51, 1826\u20131834. https:\/\/doi.org\/10.1007\/s00125-008-1089-6 (2008).","journal-title":"Diabetologia"},{"key":"37120_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","volume":"49","author":"P Zhang","year":"2017","unstructured":"Zhang, P. et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann. Med. 49, 106\u2013116. https:\/\/doi.org\/10.1080\/07853890.2016.1231932 (2017).","journal-title":"Ann. Med."},{"key":"37120_CR6","doi-asserted-by":"publisher","first-page":"5445349","DOI":"10.1155\/2021\/5445349","volume":"2021","author":"L Qian","year":"2021","unstructured":"Qian, L. et al. Integrated bioinformatics-based identification of potential diagnostic biomarkers associated with diabetic foot ulcer development. J. Diabetes Res. 2021, 5445349. https:\/\/doi.org\/10.1155\/2021\/5445349 (2021).","journal-title":"J. Diabetes Res."},{"key":"37120_CR7","doi-asserted-by":"publisher","first-page":"110991","DOI":"10.1016\/j.biopha.2020.110991","volume":"133","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed. Pharmacother. 133, 110991. https:\/\/doi.org\/10.1016\/j.biopha.2020.110991 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"37120_CR8","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1038\/s41467-021-25557-9","volume":"12","author":"L Atta","year":"2021","unstructured":"Atta, L. & Fan, J. Computational challenges and opportunities in spatially resolved transcriptomic data analysis. Nat. Commun. 12, 5283. https:\/\/doi.org\/10.1038\/s41467-021-25557-9 (2021).","journal-title":"Nat. Commun."},{"key":"37120_CR9","doi-asserted-by":"publisher","first-page":"12310","DOI":"10.1038\/s41598-021-91625-1","volume":"11","author":"BL Le","year":"2021","unstructured":"Le, B. L. et al. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Sci. Rep. 11, 12310. https:\/\/doi.org\/10.1038\/s41598-021-91625-1 (2021).","journal-title":"Sci. Rep."},{"key":"37120_CR10","doi-asserted-by":"publisher","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","volume":"3","author":"JT Dudley","year":"2011","unstructured":"Dudley, J. T. et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med. 3, 96ra76. https:\/\/doi.org\/10.1126\/scitranslmed.3002648 (2011).","journal-title":"Sci. Transl. Med."},{"key":"37120_CR11","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jid.2016.03.001","volume":"136","author":"HG Cho","year":"2016","unstructured":"Cho, H. G., Fiorentino, D., Lewis, M., Sirota, M. & Sarin, K. Y. Identification of alpha-adrenergic agonists as potential therapeutic agents for dermatomyositis through drug-repurposing using public expression datasets. J. Invest. Dermatol. 136, 1517\u20131520. https:\/\/doi.org\/10.1016\/j.jid.2016.03.001 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"37120_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1053\/j.gastro.2017.02.039","volume":"152","author":"B Chen","year":"2017","unstructured":"Chen, B. et al. Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology 152, 2022\u20132036. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.039 (2017).","journal-title":"Gastroenterology"},{"key":"37120_CR13","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/ncomms16022","volume":"8","author":"B Chen","year":"2017","unstructured":"Chen, B. et al. Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat. Commun. 8, 16022. https:\/\/doi.org\/10.1038\/ncomms16022 (2017).","journal-title":"Nat. Commun."},{"key":"37120_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","volume":"3","author":"NS Jahchan","year":"2013","unstructured":"Jahchan, N. S. et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 3, 1364\u20131377. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0183 (2013).","journal-title":"Cancer Discov."},{"key":"37120_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133761","author":"BL Le","year":"2020","unstructured":"Le, B. L., Iwatani, S., Wong, R. J., Stevenson, D. K. & Sirota, M. Computational discovery of therapeutic candidates for preventing preterm birth. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.133761 (2020).","journal-title":"JCI Insight"},{"key":"37120_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010113","author":"W Adikusuma","year":"2022","unstructured":"Adikusuma, W. et al. Identification of druggable genes for asthma by integrated genomic network analysis. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines10010113 (2022).","journal-title":"Biomedicines"},{"key":"37120_CR17","doi-asserted-by":"publisher","first-page":"724277","DOI":"10.3389\/fimmu.2021.724277","volume":"12","author":"W Adikusuma","year":"2021","unstructured":"Adikusuma, W. et al. Drug repurposing for atopic dermatitis by integration of gene networking and genomic information. Front. Immunol. 12, 724277. https:\/\/doi.org\/10.3389\/fimmu.2021.724277 (2021).","journal-title":"Front. Immunol."},{"key":"37120_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381. https:\/\/doi.org\/10.1038\/nature12873 (2014).","journal-title":"Nature"},{"key":"37120_CR19","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1038\/ncomms10531","volume":"7","author":"M Imamura","year":"2016","unstructured":"Imamura, M. et al. Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes. Nat. Commun. 7, 10531. https:\/\/doi.org\/10.1038\/ncomms10531 (2016).","journal-title":"Nat. Commun."},{"key":"37120_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","volume":"22","author":"WR Reay","year":"2021","unstructured":"Reay, W. R. & Cairns, M. J. Advancing the use of genome-wide association studies for drug repurposing. Nat. Rev. Genet. 22, 658\u2013671. https:\/\/doi.org\/10.1038\/s41576-021-00387-z (2021).","journal-title":"Nat. Rev. Genet."},{"key":"37120_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jss.2009.09.012","volume":"167","author":"L Pradhan","year":"2011","unstructured":"Pradhan, L. et al. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J. Surg. Res. 167, 336\u2013342. https:\/\/doi.org\/10.1016\/j.jss.2009.09.012 (2011).","journal-title":"J. Surg. Res."},{"key":"37120_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2017.06.020","volume":"296","author":"JP Niemi","year":"2017","unstructured":"Niemi, J. P. et al. Injury-induced gp130 cytokine signaling in peripheral ganglia is reduced in diabetes mellitus. Exp. Neurol. 296, 1\u201315. https:\/\/doi.org\/10.1016\/j.expneurol.2017.06.020 (2017).","journal-title":"Exp. Neurol."},{"key":"37120_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103217","author":"A Ridiandries","year":"2018","unstructured":"Ridiandries, A., Tan, J. T. M. & Bursill, C. A. The role of chemokines in wound healing. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19103217 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"37120_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1523-1747.2000.00034.x","volume":"115","author":"RM Devalaraja","year":"2000","unstructured":"Devalaraja, R. M. et al. Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 115, 234\u2013244. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00034.x (2000).","journal-title":"J. Invest. Dermatol."},{"key":"37120_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.37796\/2211-8039.1279","volume":"12","author":"R Nanda","year":"2022","unstructured":"Nanda, R., Patel, S., Ghosh, A., Asha, K. S. & Mohapatra, E. A study of apolipoprotein A1(ApoA1) and interleukin-10(IL-10) in diabetes with foot ulcers. Biomedicine (Taipei) 12, 30\u201338. https:\/\/doi.org\/10.37796\/2211-8039.1279 (2022).","journal-title":"Biomedicine (Taipei)"},{"key":"37120_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.2353\/ajpath.2009.080765","volume":"174","author":"AA Thomay","year":"2009","unstructured":"Thomay, A. A. et al. Disruption of interleukin-1 signaling improves the quality of wound healing. Am. J. Pathol. 174, 2129\u20132136. https:\/\/doi.org\/10.2353\/ajpath.2009.080765 (2009).","journal-title":"Am. J. Pathol."},{"key":"37120_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s42003-021-01913-9","volume":"4","author":"JL Tan","year":"2021","unstructured":"Tan, J. L. et al. Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist. Commun. Biol. 4, 422. https:\/\/doi.org\/10.1038\/s42003-021-01913-9 (2021).","journal-title":"Commun. Biol."},{"key":"37120_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","volume":"17","author":"J Ramirez","year":"2018","unstructured":"Ramirez, J. & Canete, J. D. Anakinra for the treatment of rheumatoid arthritis: A safety evaluation. Expert Opin. Drug Saf. 17, 727\u2013732. https:\/\/doi.org\/10.1080\/14740338.2018.1486819 (2018).","journal-title":"Expert Opin. Drug Saf."},{"key":"37120_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/art.10870","volume":"48","author":"RM Fleischmann","year":"2003","unstructured":"Fleischmann, R. M. et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis Rheum. 48, 927\u2013934. https:\/\/doi.org\/10.1002\/art.10870 (2003).","journal-title":"Arthritis Rheum."},{"key":"37120_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41467-021-27801-8","volume":"13","author":"G Theocharidis","year":"2022","unstructured":"Theocharidis, G. et al. Single cell transcriptomic landscape of diabetic foot ulcers. Nat. Commun. 13, 181. https:\/\/doi.org\/10.1038\/s41467-021-27801-8 (2022).","journal-title":"Nat. Commun."},{"key":"37120_CR31","doi-asserted-by":"publisher","first-page":"997880","DOI":"10.3389\/fendo.2022.997880","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq. Front. Endocrinol. (Lausanne) 13, 997880. https:\/\/doi.org\/10.3389\/fendo.2022.997880 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"37120_CR32","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"37120_CR33","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"key":"37120_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.drudis.2007.07.011","volume":"12","author":"H Ruffner","year":"2007","unstructured":"Ruffner, H., Bauer, A. & Bouwmeester, T. Human protein-protein interaction networks and the value for drug discovery. Drug Discov. Today 12, 709\u2013716. https:\/\/doi.org\/10.1016\/j.drudis.2007.07.011 (2007).","journal-title":"Drug Discov. Today"},{"key":"37120_CR35","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: Gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199\u2013W205. https:\/\/doi.org\/10.1093\/nar\/gkz401 (2019).","journal-title":"Nucleic Acids Res."},{"key":"37120_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha, A. et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J. Clin. Immunol. 40, 66\u201381. https:\/\/doi.org\/10.1007\/s10875-020-00758-x (2020).","journal-title":"J. Clin. Immunol."},{"key":"37120_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"37120_CR38","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour, S. L. et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144\u2013D1151. https:\/\/doi.org\/10.1093\/nar\/gkaa1084 (2021).","journal-title":"Nucleic Acids Res."},{"key":"37120_CR39","doi-asserted-by":"publisher","unstructured":"Wickham H. Ggplot2: Elegant Graphics for Data Analysis. 2nd edn (Springer, 2009). https:\/\/doi.org\/10.1007\/978-0-387-98141-3.","DOI":"10.1007\/978-0-387-98141-3"},{"key":"37120_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen, H. & Boutros, P. C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform. 12, 35. https:\/\/doi.org\/10.1186\/1471-2105-12-35 (2011).","journal-title":"BMC Bioinform."},{"key":"37120_CR41","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize Implements and enhances circular visualization in R. Bioinformatics 30, 2811\u20132812. https:\/\/doi.org\/10.1093\/bioinformatics\/btu393 (2014).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37120-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T17:07:08Z","timestamp":1687280828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37120-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37120"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37120-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"5 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10032"}}